Pilot Study

 Pilot Study Group Photo

Detroit, Michigan

In 2016, leading physicians from 4 hospital systems in Detroit (Henry Ford, DMC, Beaumont, and St. Joseph Mercy) got together to make the first improvements in Cardiogenic Shock survival in over 20 years. Similar to how these same physicians worked together to help define STEMI treatment and door-to-balloon time, they are now working to revolutionize treatment of cardiogenic shock utilizing data collected over the past 10 years.

From July 2016 to February 2017, a pilot study was done assessing the data on 41 enrolled patients using the Detroit CSI protocol based on best practices and currently available devices. The initial results showed an in crease in CGS survival from 51% to 76%.

The protocol has 3 pillars for success:

  1. Rapid Door to Support time (placement of the Mechanical Circulatory Support)
  2. Aggressive reduction in the use of inotropic/vasopressive medications post-procedure (as monitored through right-heart pressures and hemodynamic measurements)
  3. Medical therapy catered using RHC/invasive hemodynamics

The Science & Studies of Cardiogenic Shock

Detroit CSI JACC March 2017

Collaboration Results and Next Steps
We had an 76% survival rate.
National Cardiogenic Shock Initiative

A National Initiative to Increase Survival